CLSI M24-A2

Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard, M24A2E

Clinical and Laboratory Standards Institute, 03/01/2011

Publisher: CLSI

File Format: PDF

$90.00$180.00

Description

Published:01/03/2011

Pages:76

File Size:1 file , 1.7 MB

Note:This product is unavailable in Russia, Belarus

This standard provides protocols and related quality control parameters and interpretive criteria for the susceptibility testing of mycobacteria, Nocardiae spp. and other aerobic actinomycetes.

More CLSI standard pdf

CLSI EP26-A

User Evaluation of Between-Reagent Lot Variation; Approved Guideline, EP26AE

$90.00 $180.00

CLSI MM07-A2 (R2018)

Fluorescence In Situ Hybridization Methods for Clinical Laboratories; Approved Guideline--Second Edition, MM07A2E

$90.00 $180.00

CLSI EP09-A3

Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline--Third Edition, EP09A3E

$110.00 $220.02

CLSI NBS01-A6

Blood Collection on Filter Paper for Newborn Screening Programs; Approved Standard - Sixth Edition, NBS01A6E

$90.00 $180.00